It has been established that high expression of the DMBT1 gene correlates with lower clinical staging, reduced risk of lymph node metastasis, and smaller tumor diameter (103), suggesting that DMBT1 may play a role in inhibiting the progression of PTC. This evidence concerns the gene DMBT1 and metastatic malignant neoplasm in the lymph nodes.